AR062258A1 - Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcv - Google Patents
Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcvInfo
- Publication number
- AR062258A1 AR062258A1 ARP070103144A ARP070103144A AR062258A1 AR 062258 A1 AR062258 A1 AR 062258A1 AR P070103144 A ARP070103144 A AR P070103144A AR P070103144 A ARP070103144 A AR P070103144A AR 062258 A1 AR062258 A1 AR 062258A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- heterocyclic
- alkyl
- heteroaryl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83104006P | 2006-07-14 | 2006-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062258A1 true AR062258A1 (es) | 2008-10-29 |
Family
ID=38742551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103144A AR062258A1 (es) | 2006-07-14 | 2007-07-13 | Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcv |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2044083A1 (ko) |
| JP (1) | JP2009543807A (ko) |
| KR (1) | KR20090033881A (ko) |
| CN (1) | CN101490058A (ko) |
| AR (1) | AR062258A1 (ko) |
| AU (1) | AU2007272441A1 (ko) |
| BR (1) | BRPI0714346A2 (ko) |
| CA (1) | CA2657651A1 (ko) |
| MX (1) | MX2009000513A (ko) |
| PE (1) | PE20080427A1 (ko) |
| RU (1) | RU2009105196A (ko) |
| TW (1) | TW200813070A (ko) |
| WO (2) | WO2008008907A2 (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
| WO2008137126A2 (en) | 2007-05-04 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Combination therapy for the treatment of hcv infection |
| AR079528A1 (es) | 2009-12-18 | 2012-02-01 | Idenix Pharmaceuticals Inc | Inhibidores de arileno o heteroarileno 5,5-fusionado del virus de la hepatitis c |
| EP2655362A1 (en) * | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis c inhibitors and uses thereof |
| US20120252721A1 (en) * | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| FR3008975A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| RU2546006C1 (ru) | 2014-03-07 | 2015-04-10 | Римма Ильинична Ашкинази | Противовирусное средство |
| US10080728B2 (en) | 2015-01-20 | 2018-09-25 | Viktor Veniaminovich Tets | Hemostatic agent |
| US10167293B2 (en) * | 2016-05-26 | 2019-01-01 | Bayer Pharma Aktiengesellschaft | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones |
| CA3064733A1 (en) | 2017-05-24 | 2018-11-29 | Viktor Veniaminovich Tets | Fractionated antimicrobial compositions and use thereof |
| US11661431B2 (en) | 2021-04-16 | 2023-05-30 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| EP4398989A1 (en) | 2021-09-10 | 2024-07-17 | Gilead Sciences, Inc. | Thienopyrrole compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0210357A (pt) * | 2001-06-11 | 2004-06-29 | Shire Biochem Inc | Composto e métodos para o tratamento ou a prevenção de infecções pelo flavivìrus |
| ZA200509590B (en) * | 2003-06-04 | 2007-04-25 | Genelabs Tech Inc | Nitrogen-containing heteroaryl derivatives for the treatment of HCV-infection |
-
2007
- 2007-07-12 MX MX2009000513A patent/MX2009000513A/es not_active Application Discontinuation
- 2007-07-12 CA CA002657651A patent/CA2657651A1/en not_active Abandoned
- 2007-07-12 KR KR1020097001707A patent/KR20090033881A/ko not_active Application Discontinuation
- 2007-07-12 CN CNA2007800266569A patent/CN101490058A/zh active Pending
- 2007-07-12 JP JP2009519699A patent/JP2009543807A/ja active Pending
- 2007-07-12 EP EP07799544A patent/EP2044083A1/en not_active Withdrawn
- 2007-07-12 BR BRPI0714346-0A patent/BRPI0714346A2/pt not_active Application Discontinuation
- 2007-07-12 WO PCT/US2007/073386 patent/WO2008008907A2/en active Application Filing
- 2007-07-12 WO PCT/US2007/073391 patent/WO2008008912A1/en active Application Filing
- 2007-07-12 AU AU2007272441A patent/AU2007272441A1/en not_active Abandoned
- 2007-07-12 RU RU2009105196/04A patent/RU2009105196A/ru not_active Application Discontinuation
- 2007-07-13 TW TW096125693A patent/TW200813070A/zh unknown
- 2007-07-13 PE PE2007000902A patent/PE20080427A1/es not_active Application Discontinuation
- 2007-07-13 AR ARP070103144A patent/AR062258A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009000513A (es) | 2009-03-09 |
| PE20080427A1 (es) | 2008-06-11 |
| AU2007272441A1 (en) | 2008-01-17 |
| RU2009105196A (ru) | 2010-08-27 |
| EP2044083A1 (en) | 2009-04-08 |
| CA2657651A1 (en) | 2008-01-17 |
| WO2008008912A1 (en) | 2008-01-17 |
| BRPI0714346A2 (pt) | 2013-03-19 |
| WO2008008907A3 (en) | 2008-03-20 |
| CN101490058A (zh) | 2009-07-22 |
| TW200813070A (en) | 2008-03-16 |
| AU2007272441A2 (en) | 2009-03-19 |
| WO2008008907A2 (en) | 2008-01-17 |
| KR20090033881A (ko) | 2009-04-06 |
| JP2009543807A (ja) | 2009-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR062258A1 (es) | Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcv | |
| AR062827A1 (es) | Inhibidores virales policiclicos, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de una infeccion viral mediada porl el virus de la hepatitis c | |
| AR066492A1 (es) | Derivados de imidazoquinolina, proceso para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de enfermedades virales, bacterianas, alergicas y distintos tipos de canceres. | |
| AR041250A1 (es) | Derivados de sulfonamida como inhibidores de enzimas convertidoras de tnf-alfa | |
| CO6270320A2 (es) | Derivados de piperidina utiles como antagonistas del receptor orexina | |
| CR8595A (es) | Inhibidor del dipeptidil-peptidasa | |
| PE20090511A1 (es) | Imidazopiridinonas | |
| AR044519A1 (es) | Derivados de piridin-tiazol amina y de pirimidin-tiazol amina | |
| BRPI0707491B8 (pt) | compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas | |
| AR056445A1 (es) | Derivados arilicos y heteroarilicos de 6 miembros para tratar virus | |
| GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| AR078786A1 (es) | Derivados de la cromenona | |
| AR064345A1 (es) | Derivados de 8-oxoadenina | |
| EA200800478A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| UY29703A1 (es) | "inhibidores macrocíclicos del virus de la hepatitis c" | |
| PE20090902A1 (es) | Combinacion de un antimitotico e inhibidor de aurora quinasa como agentes anticancerigenos | |
| ES2422204T3 (es) | Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS) | |
| AR080596A1 (es) | Compuestos alquilamido y composiciones farmaceuticas | |
| AR065280A1 (es) | Agentes antiparasitarios | |
| AR071283A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| BRPI0511933B8 (pt) | derivados de quinazolinona, seu uso e seu processo de preparação, e composição farmacêutica | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| PE20080608A1 (es) | Compuestos quimicos | |
| AR077043A2 (es) | Pirimidinonas biciclicas y sus usos | |
| PE20140716A1 (es) | Compuestos y su usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |